Olsen Catherine M, Neale Rachel E, Green Adèle C, Webb Penelope M, Whiteman David C
Cancer Control Group, Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Cancer Control Group, Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Cancer Research UK Manchester Institute and Institute of Inflammation and Repair, University of Manchester, Manchester, UK.
J Invest Dermatol. 2015 May;135(5):1377-1384. doi: 10.1038/jid.2014.533. Epub 2014 Dec 30.
Identifying people at high risk of melanoma is important for targeted prevention activities and surveillance. Several tools have been developed to classify melanoma risk, but few have been independently validated. We assessed the discriminatory performance of six melanoma prediction tools by applying them to individuals from two independent data sets, one comprising 762 melanoma cases and the second a population-based sample of 42,116 people without melanoma. We compared the model predictions with actual melanoma status to measure sensitivity and specificity. The performance of the models was variable with sensitivity ranging from 97.7 to 10.5% and specificity from 99.6 to 1.3%. The ability of all the models to discriminate between cases and controls, however, was generally high. The model developed by MacKie et al. (1989) had higher sensitivity and specificity for men (0.89 and 0.88) than women (0.79 and 0.72). The tool developed by Cho et al. (2005) was highly specific (men, 0.92; women, 0.99) but considerably less sensitive (men, 0.64; women, 0.37). Other models were either highly specific but lacked sensitivity or had low to very low specificity and higher sensitivity. Poor performance was partly attributable to the use of non-standardized assessment items and various differing interpretations of what constitutes "high risk".
识别黑色素瘤高危人群对于开展有针对性的预防活动和监测至关重要。目前已开发出多种工具用于对黑色素瘤风险进行分类,但经过独立验证的却很少。我们将六种黑色素瘤预测工具应用于两个独立数据集的个体,以评估它们的区分性能。其中一个数据集包含762例黑色素瘤病例,另一个是基于人群的42116名无黑色素瘤者的样本。我们将模型预测结果与黑色素瘤实际患病情况进行比较,以测量敏感性和特异性。各模型的性能各不相同,敏感性范围为97.7%至10.5%,特异性范围为99.6%至1.3%。然而,所有模型区分病例和对照的能力总体上较高。MacKie等人(1989年)开发的模型对男性的敏感性和特异性(分别为0.89和0.88)高于女性(分别为0.79和0.72)。Cho等人(2005年)开发的工具特异性很高(男性为0.92,女性为0.99),但敏感性相当低(男性为0.64,女性为0.37)。其他模型要么特异性很高但缺乏敏感性,要么特异性很低至极低但敏感性较高。表现不佳部分归因于使用了未标准化的评估项目以及对“高危”构成的各种不同解释。